IDEAYA Biosciences, Inc.
7000 Shoreline Court, Suite 350
South San Francisco, California 94080
June 9, 2020
VIA EDGAR AND E-MAIL
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549-6010
Attention: Alan Campbell, Attorney Advisor
| Re: | IDEAYA Biosciences, Inc. Registration Statement on Form S-3 (Registration No. 333-238849) |
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended, we hereby request acceleration of the effective date of the Registration Statement on Form S-3 (File No. 333-238849) (the “Registration Statement”) of IDEAYA Biosciences, Inc. (the “Company”). We respectfully request that the Registration Statement become effective as of 4:00 p.m., Washington, D.C. time, on June 10, 2020, or as soon as practicable thereafter. Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Latham & Watkins LLP, by calling Mark Roeder at (650) 463-3043.
Thank you for your assistance in this matter.
Very truly yours,
IDEAYA BIOSCIENCES, INC. | ||
| By: | /s/ Jason S. Throne | |
Jason S. Throne | ||
Vice President, General Counsel | ||
| CC: | Yujiro Hata, IDEAYA Biosciences, Inc. |
Paul A. Stone, Esq., IDEAYA Biosciences, Inc.
Mark V. Roeder, Esq., Latham & Watkins LLP
Alexander T. White, Esq., Latham & Watkins LLP
